Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia.
Negevesky
G J
GJ
Kolsky
M P
MP
Laureno
R
R
Yau
T H
TH
D001259:Ataxia / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D000069059:Atorvastatin; D001323:Autoantibodies / Q000097:blood*; D005260:Female; D006538:Heptanoic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D008875:Middle Aged; D009886:Ophthalmoplegia / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology*; D014792:Visual Acuity
D001323:Autoantibodies; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D011950:Receptors, Cholinergic; D000069059:Atorvastatin